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TO THE EDITOR
Optimization of laser therapy for disfig-
uring vascular birthmarks is one specific
clinical application (Kelly et al., 2005).
Current treatment protocols involve the
use of high-power pulsed laser irradia-
tion with parameters chosen to induce
selective photocoagulation of the tar-
geted blood vessels, a method known as
selective photothermolysis (Anderson
and Parrish, 1983). Protocol design is
based largely on results from numerical
modeling studies (van Gemert et al.,
1997), which are designed to predict the
laser light distribution within the skin
and subsequent photothermal response
leading toward selective photocoagula-
tion. However, current modeling meth-
ods do not incorporate adequately the
complex dynamics associated with
changes in light absorption due to
conversion of hemoglobin to methemo-
globin (Barton et al., 2001; Kimel et al.,
2005) and convective mixing of blood
during pulsed laser irradiation (Kimel
et al., 2003), limiting their overall
predictive capability. Furthermore,
these models do not consider the
chronic, biological response of the
microvasculature to therapeutic laser
intervention, which remains a poorly
researched field. Knowledge of the
biological response is critical to under-
stand the repair processes initiated with
photothermal injury and to assess the
ultimate efficacy of the treatment.
Animal models used as a platform to
study light-based, microvascular-tar-
geted therapies include the chick chor-
ioallantoic membrane (Kimel et al.,
1994, 2003), hamster cheek pouch
(Suthamjariya et al., 2004), and rodent
dorsal window chamber (Barton et al.,
1998, 1999, 2001; Choi et al., 2004;
Babilas et al., 2005; Smith et al., 2006).
Optical imaging modalities used to
evaluate noninvasively therapeutic out-
come include video imaging, fluores-
cence microscopy, Doppler optical
coherence tomography, and laser
speckle imaging. Typically, short-term
(o24 hours after intervention) evalua-
tion of the microvasculature is per-
formed. Babilas et al. (2005) proposed
that a (1) 24-hour monitoring period
allows for evaluation of ‘‘delayed bio-
logical effects’’ in the microvascular
response to pulsed laser irradiation, and
(2) the short-term response correlates
well with numerical modeling predic-
tions of photocoagulation. Longer
(424 hour after intervention) monitor-
ing periods usually are not performed
with nontumor-bearing window cham-
bers, presumably due to the reduced
clarity of the chamber imposed by
poor maintenance of window integrity
secondary to infection. However,
we hypothesized that the short-term
response of the microvasculature is
a poor predictor of the long-term
response. With emphasis on aseptic
methods, we have been able to main-
tain clear window chamber prepara-
tions for as long as 45 days after
intervention. With this model, we have
studied the long-term microvascular
response to light-based, microvascular-
targeted therapies.
The data presented herein were
acquired from adult male Golden Syr-
ian hamsters. The surgery was per-
formed as defined in a protocol
approved by the University of Califor-
nia, Irvine, Animal Use Committee. The
surgical protocol was a modified ver-
sion of one described previously
(Papenfuss et al., 1979). For all steps,
aseptic conditions were maintained.
We used wide-field color reflectance
imaging and laser speckle imaging
(Choi et al., 2004, 2006; Smith et al.,
2006) to document and evaluate quan-
titatively and chronically ensuing blood
flow dynamics. In one set of experi-
ments, we irradiated select arteriole-
venule pairs with laser pulse sequences
to evaluate the efficacy of various
therapeutic protocols. In the presented
example (Figure 1a), we irradiated an
arteriole-venule pair (upper circle in
‘‘Before’’ image) with five laser pulses
containing both 532 and 1064nm laser
wavelengths and a second pair (lower
circle) with a single 532/1064nm laser
pulse. Numerical modeling data sug-
gested that both sets of laser parameters
should induce photocoagulation in the
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targeted vessels (Dr Wangcun Jia,
unpublished data). The short-term
response was characterized primarily
by photocoagulation events, with a
substantial-to-complete venular flow
reduction and considerable arteriolar
flow reduction, a trend in agreement
with data presented by Barton et al.
(1999). At 24 hours after intervention,
the arteriolar flow (circle in day 1
speckle flow index image) was absent.
At later time points, partial-to-com-
plete restoration of blood flow in these
photocoagulated vessels was observed
(Figures 1a and b). In general, we obser-
ved several microvascular dynamics,
including vasoconstriction, vasodila-
tion, and delayed blood flow changes,
in both directly irradiated and nonirra-
diated vessels. We have observed
shunting of blood flow to tortuous
collateral vessels (i.e., indicated by
arrow in day 6 image). Furthermore,
we have observed vessel repair within
the same position as the original vessel
(i.e., indicated by arrows in day 15 and
day 21 images), suggesting that the
vascular remodeling process may be
associated with a ‘‘memory’’, in agree-
ment with published tumor angiogen-
esis data (Mancuso et al., 2006).
In a second set of experiments, we
evaluated the efficacy of photodynamic
therapy as a photochemical method to
destroy the microvasculature. Two days
after window chamber installation, we
installed a jugular vein catheter for
intravenous access, injected the photo-
sensitizer benzoporphyrin monoacid ring
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Figure 1. Microvascular blood flow response after pulsed laser irradiation. (a) Time sequence of wide-field color reflectance images (top row) and
corresponding speckle flow index (SFI) images (bottom row) acquired over a 21-day monitoring period after pulsed laser irradiation of selected sites. Two
arteriole-venule pairs (dashed circles in ‘‘Before’’ image) were irradiated with simultaneous 532 and 1064 nm laser pulses (upper circle—five 1-ms laser pulses at
27Hz repetition rate, 2 J/cm2 at 532 nm, 3.6 J/cm2 at 1064 nm; lower circle—single 1-ms laser pulse, 4 J/cm2 at 532 nm, 7.2 J/cm2 at 1064 nm). Vascular
remodeling and blood flow dynamics were evident during the 21-day monitoring period, with the day 0 and day 21 structural images having similar
appearances. (b) Quantitative evaluation of selected blood vessel regions of interest. In all three regions, the blood flow was shut down immediately, followed by
eventual reperfusion to near-baseline blood flow levels. Color reflectance image dimensions (HV): 13 10mm2; SFI image dimensions: 9 7mm2.
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A, and used 576nm laser light to excite
the benzoporphyrin monoacid ring A.
The experimental protocol was similar to
the one we published previously (Smith
et al., 2006). At 24hours post-photody-
namic therapy, we have observed a
considerable shutdown of the microcir-
culation in the entire window (Figure 2,
day 1). However, starting at 3 days post-
photodynamic therapy, we have ob-
served a progressive, partial recovery of
blood flow, illustrating once again the
role of the biological response in mediat-
ing the ensuing hemodynamics.
Collectively, our data strongly sug-
gest that the short-term (o24 hours)
microvascular response to light-based
therapeutic intervention differs consider-
ably from the long-term response. We
believe this is due to the biological
repair response, which is not taken into
account in current theoretical models.
Such events have not been observed in
previous studies on nontumor-bearing
window chambers presumably due to
tissue regrowth, which we have demon-
strated can be minimized with main-
tenance of an aseptic surgical field. We
have observed considerable vascular
remodeling events and at least partial
restoration of blood flow within initially
photocoagulated blood vessels. Our
animal model and optical imaging
instrumentation allow us to perform
chronic evaluation of novel therapeutic
approaches designed to alter the micro-
circulation. Long-term evaluation is
probably essential to provide mean-
ingful data that can result ultimately in
improved therapeutic outcome. For
such evaluation, laser speckle imaging
also can be used to perform ‘‘image-
guided microscopy’’, to assess quanti-
tatively the wide-field microvascular
blood flow response to therapy. This
information would be useful in judi-
cious selection of specific regions of
interest to probe further with higher
resolution imaging modalities such
as multiphoton microscopy or optical
coherence tomography.
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Figure 2. Microvascular blood flow response, assessed with laser speckle imaging, after photodynamic
therapy. An B4-mm diameter air bubble was present in the day 0 images, but it had no apparent effect
on the speckle flow index (SFI) values. Benzoporphyrin monoacid ring A (1.5mg/kg body mass) was
administered via a jugular vein catheter. Fifteen minutes after benzoporphyrin monoacid ring A injection,
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TO THE EDITOR
The mitogen-activated protein kinase
signaling pathway plays an important
role in cell proliferation, differentiation
and survival and is frequently altered in
cancer. Genetic mechanisms that acti-
vate the mitogen-activated protein-
kinase pathway vary among subtypes
of melanoma when tumors are classi-
fied according to a combination of sun
exposure and anatomic site (Maldona-
do et al., 2003; Curtin et al., 2005,
2006). NRAS (neuroblastoma ras viral
oncogene homolog), which is part of
the RAS/RAF/mitogen-activated protein-
kinase signaling cascade, is mutated in
10–20% of melanomas regardless of
anatomic site. In contrast, v-raf murine
sarcoma viral oncogene homolog B1
(BRAF) mutations are frequent (about
60%) in melanomas occurring on skin
without signs of chronic sun-induced
damage (CSD) (non-CSD melanomas),
but infrequent in melanomas that occur
on skin showing evidence of CSD as
well as on sun-protected skin such as
the palms, soles, or subungual sites
(acral melanomas), and on mucosal
membranes (mucosal melanomas) (Mal-
donado et al., 2003; Curtin et al., 2005).
We have recently reported increased
copy numbers of chromosome 4q12
and identified v-kit Hardy-Zuckerman
4 feline sarcoma viral oncogene homo-
log (KIT) as a somatic target that is
activated in CSD, acral, and mucosal
melanoma. This genomic region con-
tains several additional genes that are
involved in other types of cancer,
including the platelet-derived growth
factor a receptor (PDGFRA). PDGFRA
is a receptor tyrosine kinase, which is
activated by mutations or small dele-
tions in a subset of gastrointestinal
stroma tumors (Heinrich et al., 2003b)
and childhood acute myeloid leukae-
mia’s (Hiwatari et al., 2005) as well as
fusion with FIP1L1 in hypereosinophilic
syndrome (Cools et al., 2003) and
systemic mastocytosis associated with
eosinophilia (Pardanani et al., 2003).
Mutation of PDGFRA or KIT occurs
infrequently in most solid tumors with
the exception of gastrointestinal stroma
tumors (Sihto et al., 2005). In gastro-
intestinal stroma tumors, mutations in
PDGFRA and KIT are mutually exclu-
sive (Heinrich et al., 2003a, b) and
tumors with either mutation can show
responses with kinase inhibitors such as
imatinib, dasatinib, and sunitinib (Hein-
rich et al., 2003a; Corless et al., 2006;
Schittenhelm et al., 2006). PDGFRA has
been found to be overexpressed in some
melanomas (Barnhill et al., 1996), rais-
ing the possibility that it could also be a
target of somatic mutations in some
melanomas. To date, a limited mutation
analysis of primary tumors did not find
mutations in PDGFRA (Curtin et al.,
2006). To address fully the role of
PDGFRA in melanoma, we analyzed a
larger set of primary melanomas for
mutations, copy number increases, and
expression of PDGFRA. To increase the
likelihood of encountering mutations,
we enriched the samples for cases that
did not have mutations of KIT or BRAF.
Specifically, we analyzed DNA ex-
tracted from archival paraffin-em-
bedded primary melanomas with an
invasive component in which tumor
cells predominated over stroma cells.
Additional analyses on some of these
cases were reported previously (Curtin
et al., 2005, 2006). Institutional Review
Board of the University of California,
San Francisco, approved the study.
From a cohort of 102, we sequenced
the 26 primary melanomas which had
increased copy number of the 4q12
locus harboring PDGFRA (n¼ 10) or
had normal copy number but did not
show mutations in KIT exons 11, 13,
17, and 18, and BRAF exon 15 (n¼ 16).
Seven of the cases were acral melano-
mas, that is melanomas from the palms,
soles, and subungual sites; 13 were
mucosal melanomas; and three were
melanomas from chronically sun-
damaged skin, and three melanoma
from skin without chronic sun damage.
CSD was defined by the microscopic
presence or absence of marked solar
elastosis of the dermis surrounding the
melanomas. Exons of interest were
amplified by PCR and sequenced as
described previously (Curtin et al.,
2005) using specific primers flanking
the common (Heinrich et al., 2003b)
mutation sites of PDGFRA; exons 10,
12, 14, and 18 (Table S1). No mutations
of PDGFRA were found in any or our
melanoma samples. Our samples con-
tained a majority of tumor cells, which
excludes the possibility that mutations
were missed owing to an excess of
stromal cells. In addition, all samples
included in this analysis showed DNA
copy number changes by CGH (Curtin
et al., 2005, 2006), which indicates that
Abbreviations: CSD, chronic sun damage; KIT, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene
homolog; NRAS, neuroblastoma ras viral oncogene homolog; PDGFRA, platelet-derived growth factor a
receptor
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